Home / Business and Economy / Revvity: On Track for Earnings Growth
Revvity: On Track for Earnings Growth
4 Jul
Summary
- Revvity revenue reached $2.9 billion in 2025.
- Company anticipates a 4.2% EPS increase this quarter.
- Stock gained 12.8% over the past year.
Revvity, Inc., a key player in life sciences and diagnostics, is set to announce its fiscal 2026 second-quarter financial results. Analysts project earnings per share of $1.23, a 4.2% rise from the prior year, building on a consistent history of surpassing earnings expectations.
The company reported a solid first quarter for fiscal 2026, with revenue climbing 7% year-over-year to $711.1 million. Both its Life Sciences and Diagnostics segments experienced significant growth.
Looking ahead, full-year fiscal 2026 EPS is forecasted at $5.25, with further growth anticipated in fiscal 2027. Revvity's stock has seen a 12.8% increase over the last twelve months, demonstrating a stable but lagging performance compared to broader market indices.
